Health care organizations face a growing wave of cyberattacks and must implement strong defenses to protect patient data and ensure operational continuity.
Health care enterprises today are plagued by increasingly sophisticated cyberattacks. To combat cyber threats—the most common being hacking, ransomware, phishing, and supply chain attacks—health care organizations must proactively operationalize key risk mitigation strategies to shore up their cyber defenses.
The HIPAA Journal reported that 2023 saw a record 725 large health care security breaches reported to the US Department of Health and Human Services Office for Civil Rights, eclipsing the record of 720 health care security breaches set the previous year.1 As a result of these breaches, an average of 373,788 health care records were breached every day in 2023.
In late February, an attack on Change Healthcare (part of Optum, a UnitedHealth Group company) impacted the company’s pharmacy, medical claims, and payment systems. The outage left some doctors unable to check patients’ eligibility for treatment or prevented them from filling prescriptions electronically. The attack also extended to financial disruption for providers who were unable to receive reimbursements from insurers.
Suggestions to minimize the impact of these cyberattacks are detailed in the sidebar (right).
As cyberattacks evolve, health care organizations can protect patients and prevent operational disruptions by using these best practice risk mitigation strategies.
For the full article and more information visit, https://bit.ly/4afUVdT
Gholam Contrasts Lenvatinib With Other Options in Child-Pugh B HCC
December 21st 2024During a Case-Based Roundtable® event, Pierre Gholam, MD, discussed how post hoc and real-world analyses build upon the limited available trial data for treating patients with unresectable hepatocellular carcinoma with Child-Pugh B status.
Read More
Ilson Examines Chemoimmunotherapy Regimens for Metastatic Gastroesophageal Cancers
December 20th 2024During a Case-Based Roundtable® event, David H. Ilson, MD, PhD, discussed the outcomes of the CheckMate 649, CheckMate 648, and KEYNOTE-859 trials of chemoimmunotherapy regimens in patients with upper GI cancers.
Read More
Participants Discuss Frontline Immunotherapy Followed by ADC for Metastatic Cervical Cancer
December 19th 2024During a Case-Based Roundtable® event, Ramez N. Eskander, MD, and participants discussed first and second-line therapy decisions for a patient with PD-L1–positive cervical cancer in the frontline metastatic setting.
Read More
Oncologists Discuss a Second-Generation BTK for Relapsed/Refractory CLL
December 18th 2024During a Case-Based Roundtable® event, Daniel A. Ermann, MD, discussed evaluation and treatment for a patient with relapsed chronic lymphocytic leukemia after receiving venetoclax and obinutuzumab.
Read More